BioTech Investors

4,602 investors · 3,559 with verified email

VCSift lists 4,602 BioTech investors, from angels writing first checks to growth funds. 3,559 of them have a verified email address on file. They include 2,166 VC firms, 2,085 angel investors and 92 accelerators. The largest groups are based in United States (588), China (179) and South Korea (74). Stages with the most investors: Seed (2,840), Growth (1,900) and Pre-Seed (519). Firms with the most BioTech investors on VCSift include Salesforce, Andreessen Horowitz and Insight Partners. Use the stage and country lists below to narrow this down to investors who match your round.

4,602 investors
CW

Connor Williams

Angel / Independent

Angel Investor
Seed Biotechnology
RM

Rob McCormack

Mustang Ventures

VC Firm
Seed Early Stage Investment Management Biotechnology Ad Tech +3 more

Frequently asked questions about BioTech investors

4,602 as of October 2026, 3,559 of them with a verified email address. They include 2,166 VC firms, 2,085 angel investors and 92 accelerators.
The largest groups are based in United States (588), China (179) and South Korea (74). Use the country lists on this page to see investors in a specific market.
Stages with the most investors: Seed (2,840), Growth (1,900), Pre-Seed (519), Series A (292) and Series C (108). Pick the stage page that matches your round before reaching out.
Firms with the most BioTech investors on VCSift include Salesforce, Andreessen Horowitz, Insight Partners, Bessemer Venture Partners and Sanofi. Each firm page lists its partners and investors with their titles and contact details.
Yes. VCSift Essentials subscribers can export up to 1,000 contacts per month as a CSV, and Pro subscribers have unlimited exports. Each row includes name, firm, title, email, LinkedIn URL, stages, sectors and location.
VCSift re-verifies email addresses on a rolling basis, removes bounced addresses, and merges new investors from public filings and firm websites. Profiles show a last-verified date where one exists.